Upcoming Biotech IPOs currently tracked by DiscoverIPO.
DiscoverIPO is tracking 7 upcoming IPOs in the Biotech. 5 of them have disclosed an offer size, the largest being Braveheart Bio, Inc. at $345M. The soonest expected date currently on record is Aug 4, 2026. All are listing on NASDAQ. Every row links to the original filing or exchange calendar entry it came from, and this page updates automatically as new filings arrive.
| Company | Industry | Country | Price range | Offer size | Expected | Status | Source |
|---|---|---|---|---|---|---|---|
| Apnimed, Inc.APMD | Pharmaceutical Preparations | United States | — | — | Not yet set | Filed with SEC | SEC EDGAR |
| Attovia Therapeutics, Inc.ATTO | Biological Products, (No Diagnostic Substances) | United States | $15.00 – $17.00 | $230M | Aug 4, 2026 | Expected | NYSE |
| BlossomHill Therapeutics, Inc.BLSM | Pharmaceutical Preparations | United States | $15.00 – $17.00 | $144M | Aug 6, 2026 | Expected | NYSE |
| Braveheart Bio, Inc.BRVE | Pharmaceutical Preparations | United States | $15.00 – $17.00 | $345M | Aug 5, 2026 | Expected | NYSE |
| Latigo Biotherapeutics, Inc.LTGO | Pharmaceutical Preparations | United States | $16.00 – $18.00 | $313M | Aug 6, 2026 | Expected | NYSE |
| Neuro Spectrum Insights, Inc. | Surgical & Medical Instruments & Apparatus | United States | — | — | Not yet set | Filed with SEC | SEC EDGAR |
| Vogenx, Inc.VOGX | Pharmaceutical Preparations | United States | $11.00 – $13.00 | $86M | Aug 5, 2026 | Expected | NYSE |
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy